Hospitals Omnicell Sterile Compounds 
Omnicell
JANUARY 10, 2023
And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations. savings per year.
Omnicell
JANUARY 10, 2023
Dennis Wright, Senior Director, Product Marketing, Omnicell As health systems navigate escalating staff shortages and increasingly complex drug therapies, the need for a high-performing pharmacy has never been greater. Total prescription drug spend in the US was $576.9
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
JANUARY 10, 2023
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.
Omnicell
SEPTEMBER 5, 2022
Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.
Omnicell
JANUARY 10, 2023
Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.
Omnicell
JANUARY 10, 2023
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.
Omnicell
JANUARY 10, 2023
Terri Albarano, MS, PharmD Director, Autonomous Pharmacy Advisory Board When patients are admitted to the hospital, they are typically focused on receiving the best care. One key area was in sterile compounding of IVs – a big risk area – in which a dosing error could have serious consequences.
Expert insights. Personalized for you.
93 
Let's personalize your content